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Expected Costs of Primary Dental Treatments and Endoscopic Sinus
Surgery for Odontogenic Sinusitis
John R. Craig, MD ; Roderick W. Tataryn, DDS; Haley C. Sibley, MD; William D. Mason, MD;
Joshua A. Deuel, DDS; Gary E. Loyd, MD, MMM; David R. Nerenz, PhD; Parul Goyal, MD
Objectives: Treatment of odontogenic sinusitis (ODS) due to apical periodontitis (AP) is highly successful when both dental treatment and endoscopic sinus surgery (ESS) are performed. Variation exists in the literature with regard to types and
timing of dental treatments and ESS when managing ODS. This study modeled expected costs of different primary dental and
sinus surgical treatment pathways for ODS due to AP.
Study Design: Decision-tree economic model.
Methods: Decision-tree models were created based on cost and treatment success probabilities. Using Medicare and consumer online databases, cost data were obtained for the following dental and sinus surgical treatments across the United
States: root canal therapy (RCTx), revision RCTx, apicoectomy, extraction, dental implant, bone graft, and ESS (maxillary,
 anterior ethmoid,  frontal). A literature review was performed to determine probabilities of dental and sinus disease resolution after different dental treatments. Expected costs were determined for primary dental extraction, RCTx, and ESS pathways, and sensitivity analyses were performed.
Results: Expected costs for the three different primary treatment pathways when dental care was in-network and all diseased sinuses opened during ESS were as follows: dental extraction ($4,753.83), RCTx ($4,677.34), and ESS ($7,319.85).
Conclusions: ODS due to AP can be successfully treated with primary dental treatments, but ESS is still frequently
required. Expected costs of primary dental extraction and RCTx were roughly equal. Primary ESS had a higher expected cost,
but may still be preferred in patients with prominent sinonasal symptoms. Patients’ insurance coverage may also impact
decision-making.
Key Words: Odontogenic sinusitis, endoscopic sinus surgery, root canal therapy, dental extraction, dental implant, cost
analysis.
Level of Evidence: N/A
Laryngoscope, 00:1–10, 2021

INTRODUCTION
Successful odontogenic sinusitis (ODS) management
approaches 95% to 100% when appropriate dental treatment and endoscopic sinus surgery (ESS) are performed.1
Treatment options vary based on the dental pathology
causing ODS. Apical periodontitis (AP) is one of the most
common causes of ODS2,3 and refers to inﬂammation and
infection of the apical periodontium caused by pulpal
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infection spreading through root apices. Periapical infection may progress to form a periapical lesion (PAL) radiographically, which can represent a cyst, granuloma, or
abscess.2 Different combinations of dental and sinus
interventions are often necessary to treat ODS due to
AP. Clinicians and patients work together through shared
decision-making to decide whether dental treatment or
ESS is performed primarily.1
Dental treatments are often pursued primarily for
ODS due to untreated AP and include RCTx or dental
extraction. If previously treated with RCTx, options
include revision RCTx, apicoectomy, or extraction.4–7 If
ODS does not resolve after dental treatment, patients
must consider revision dental procedures, ESS, or both.
Additionally, if patients select extraction, they must
decide on dental reconstructive options: none, partial denture, bridge, or dental implant with or without maxillary
sinus bone grafting (MSG).8
In some ODS cases, patients may undergo ESS primarily. Although some studies suggest ESS only after
dental treatment failures,9–12 others have shown primary
ESS to be an option for faster symptom resolution,
followed by appropriate dental management.13–15 Extent
of ESS should also be considered. While most studies to
date have reported addressing all diseased sinuses during
ESS,13,16–19 recent series have demonstrated maxillary
Craig et al.: Costs of ODS Management

1

antrostomy alone to be successful regardless of sinusitis
extent.20,21
Choosing the optimal ODS treatment is difﬁcult due
to low publication volume and quality22 and logistical
challenges of coordinating multidisciplinary care between
otolaryngologists and dental specialists. In the absence of
high-quality evidence to guide management, it would be
helpful to understand the potential costs of different
treatment options. The purposes of this study were to outline treatment pathways for ODS due to AP, and to model
expected costs of these dental and sinus surgical
treatments.

MATERIALS AND METHODS
Economic Model
Decision-tree economic models were created to analyze dental treatment and ESS costs for uncomplicated ODS due to AP in
US dollars in 2021. Different dental treatments were simulated
if they had published success rates for treating AP or ODS. After
review by an endodontist (R.W.T.), oral-maxillofacial surgeon
(J.D.), anesthesiologist (G.E.L.), and rhinologists (J.R.C., P.G.), three
different primary treatment pathways were modeled: dental
extraction, RCTx, and ESS. Figures 1 to 3 are representative
decision-tree diagrams illustrating the treatment pathways when

patients had in-network dental care, and all diseased sinuses
opened during ESS.
Figure 1 shows the primary dental extraction pathway.
After extraction, patients could have complete ODS resolution,
then consider reconstructive options (none, partial denture,
bridge, or dental implant). Alternatively, they could require ESS
to resolve persistent sinusitis, followed by dental reconstructive
options.
Figure 2 shows the primary RCTx pathway. After RCTx,
patients could have ﬁve initial outcomes. First, they could have
AP and ODS resolution. They could also have AP resolution but
persistent ODS, and require only subsequent ESS. They could
also have no resolution of both AP and ODS, and require secondary dental treatments (revision RCTx, apicoectomy, or extraction), followed by subsequent dental or sinus surgical treatments
until AP and ODS resolution.
Figure 3 shows the primary ESS pathway. After ESS,
patients would undergo either RCTx or dental extraction. Treatment options thereafter mirrored the possible dental treatments
from extraction or RCTx pathways.

Probabilities
PubMed literature searches were performed to determine
success probabilities of different dental treatments for ODS due
to AP. Note that for dental treatment of ODS due to AP, there is
a success probability for resolving AP and a separate probability

Fig. 1. Primary dental extraction decision-tree diagram. Probabilities are shown below respective treatments or outcomes, and each represents the probability of the treatment or outcome occurring after the previous intervention to the left of it in the diagram. ESS = endoscopic
sinus surgery; MSG = maxillary sinus bone grafting; ODS = odontogenic sinusitis. [Color ﬁgure can be viewed in the online issue, which is
available at www.laryngoscope.com.]
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Fig. 2. Primary root canal therapy (RCTx) decision-tree diagram. Probabilities are shown below respective treatments or outcomes, and each
represents the probability of the treatment or outcome occurring after the previous intervention to the left of it in the diagram. The “plus
Reconstructive Options” shorthand refers to the reconstructive options (none, partial denture, bridge, dental implant) depicted in primary dental extraction pathway from Figure 1. AP = apical periodontitis; ESS = endoscopic sinus surgery; MSG = maxillary sinus bone grafting;
ODS = odontogenic sinusitis. [Color ﬁgure can be viewed in the online issue, which is available at www.laryngoscope.com.]

for resolving ODS. Dental extraction was the only primary dental
treatment for which success rates were published for
resolving ODS.
For mean success of RCTx, revision RCTx, and apicoectomy
at resolving AP, systematic reviews and large prospective studies
were included. For mean success of dental extraction at resolving
ODS, all published case series and cohort studies were included.
There were also points in decision trees where likelihoods of
performing different revision dental treatments, or reconstructive

Laryngoscope 00: 2021

options after extraction, were determined by expert opinion due to
data absence in the literature.
For ESS simulation, surgery extent was modeled with
either all diseased sinuses being opened or maxillary alone.
When all diseased sinuses were opened, probabilities of
opening maxillary (30%), maxillary plus anterior ethmoid
(30%), or maxillary plus anterior ethmoid and frontal
sinuses (40%) were estimated based on a recent ODS literature review.2

Craig et al.: Costs of ODS Management
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Fig. 3. Primary endoscopic sinus surgery decision-tree diagram. Probabilities are shown below respective treatments or outcomes, and each
represents the probability of the treatment or outcome occurring after the previous intervention to the left of it in the diagram. The “plus
Reconstructive Options” shorthand refers to the reconstructive options depicted after extraction following primary ESS in the lowest portion of
this diagram. ESS = endoscopic sinus surgery; MSG = maxillary sinus bone grafting; ODS = odontogenic sinusitis. [Color ﬁgure can be
viewed in the online issue, which is available at www.laryngoscope.com.]

Table I shows assumptions made when structuring the
treatment models. Table II shows the mean probabilities utilized
in different treatment models, with supporting references.
The most complex model was primary RCTx (Fig. 3). RCTx
was approximated to have a 48% success rate for treating both
AP and ODS, leaving 52% probability to be divided between the
other four possible treatment paths. As RCTx had an 80% success probability for resolving AP, a 2  2 probability table
yielded a 32% probability of RCTx successfully resolving AP but
not ODS. If RCTx failed to resolve both AP and ODS, equal probabilities were assumed for revision RCTx, apicoectomy, and

Laryngoscope 00: 2021

4

extraction. Subsequent branches in the model followed the same
methodology until resolution of both AP and ODS.

Costs
Different dental procedure costs were obtained by searching
for in-network and out-of-network costs of Current Dental Terminology (CDT) codes on an online consumer database.23 Different
ESS costs were obtained by searching Current Procedural Terminology (CPT) codes in Medicare databases.24,25 ESS costs were

Craig et al.: Costs of ODS Management

TABLE I.
Assumptions to Structure Decision-Tree Models.
Assumptions
1. All treatment pathways would eventually lead to 100% ODS resolution.
2. Dental extraction would resolve AP with 100% success.
3. After primary dental extraction, equal probabilities were assigned to the likelihoods of patients choosing no reconstruction, partial dentures, bridges, and
dental implants.
4. For maxillary dental implants, 90% of patients would require MSG.
5. Maxillary dental implants and MSG would be performed with 100% success.
6. Probabilities of success of RCTx, revision RCTx, and apicoectomy at resolving ODS would equal the probability of each of their successes at resolving AP,
multiplied by the probability of success of dental extraction at resolving ODS.
7. Unsuccessful dental treatment would never resolve ODS.
8. Primary ESS alone would never resolve ODS due to AP completely, and therefore would always be followed with either RCTx or dental extraction.
9. Dental treatments after primary ESS would be as successful as primary dental treatments at resolving ODS.
10. Secondary ESS after appropriate primary dental treatment would resolve ODS with 100% success, both for maxillary antrostomy alone and for all diseased
sinuses being opened.
11. For each set of branches in the decision trees, probabilities of given treatments being performed must sum to 100%.
AP = apical periodontitis; ESS = endoscopic sinus surgery; MSG = maxillary sinus bone grafting; ODS = odontogenic sinusitis; RCTx = root canal
therapy.

TABLE II.
Model Reference Data for Treatment Success Probabilities.
Parameters in Tree Diagrams

Probabilities

Sources

Probability of ODS resolution after extraction

0.60

Mattos et al.,36 Tomomatsu et al.,37 Tsuzuki et al.,38 Yoo
et al.,9 Simuntis et al.10

Probability of no reconstruction after extraction

0.25

Expert opinion

Probability of each reconstructive option after extraction

0.25

Expert opinion

Probability of dental implant with no MSG

0.10

Expert opinion

Probability of MSG for dental implant

0.90

Expert opinion

Probability of AP resolution after RCTx

0.80

Friedman et al.,45 Torbinejad et al.,4 Ricucci et al.46

Probability of ODS resolution after RCTx

0.48

0.60 (probability of RCTx success for AP)

Probability of each dental treatment after RCTx

0.067

2  2 probability table

Probability of AP resolution, but persistent ODS after RCTx (requiring ESS)

0.32

2  2 probability table

Extraction-related probabilities

RCTx-related probabilities

Probability of AP resolution after revision RCTx

0.78

Ng et al.,47 Torabinejad et al.,5 Chercoles-Ruiz et al.6

Probability of ODS resolution after revision RCTx

0.46

0.60 (probability of revision RCTx success for AP)

Probability of each dental treatment after revision RCTx

0.11

2  2 probability table

Probability of AP resolution, but persistent ODS after revision RCTx
(requiring ESS)

0.32

2  2 probability table

Probability of AP resolution after apicoectomy

0.74

Torabinejad et al.,5 Chercoles-Ruiz et al.6

Probability of ODS resolution after apicoectomy

0.45

0.60 (probability of Apicoectomy success for AP)

Probability of after extraction after apicoectomy

0.26

2  2 probability table

Probability of AP resolution, but persistent ODS after apicoectomy
(requiring ESS)

0.29

2  2 probability table

ESS-related probabilities
Probability of extraction after ESS

0.50

Expert opinion

Probability of RCTx after ESS

0.50

Expert opinion

AP = apical periodontitis; ESS = endoscopic sinus surgery; MSG = maxillary sinus bone grafting; ODS = odontogenic sinusitis; RCTx = root canal
therapy.

determined by adding facility24 and ambulatory surgery center
fees.25 CDT and CPT code searches were performed between
January and April 2021. Codes were searched across nine metropolitan zip codes in the nine US regions according to the
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census.26 Mean costs with 95% conﬁdence intervals (CIs) were
calculated for all CDT and CPT codes across all zip codes.
Clinic visits were also modeled. For each dental treatment
or reconstructive option, models included one pretreatment

Craig et al.: Costs of ODS Management
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Table III.
Model Reference Data for Costs of Dental and Sinus Surgical Treatments.
CDT or CPT Codes
Dental Treatment Options (Plus Clinic Visit Cost)

Costs
Dental In-Network

Extraction

D7210

RCTx
Revision RCTx
Apicoectomy

Dental Out-of-Network

$328.55

$528.00

D3330 + D2740

$2,399.33

$3,072.12

D3348 + D2391

$1,643.89

$2,129.12

D3425 + D3426 + D3430 (x2)

$2,018.78

$2,756.34

D6010 + D6066 + D6011

$4,276.69

$5,769.59

D7951

$2,128.33

$2,771.89

D6242 + D6750 (x2)

$3,065.56

$4,513.44

D5213

$1.496.11

$2,238.89

Reconstructive options after extraction (plus clinic visit
cost)
Dental Implant
MSG
Maxillary bridge
Partial maxillary denture
Sinus Surgery Options (Plus Clinic Visit Costs)

ESS Costs

ESS (all diseased sinuses)

31276 (0.4) + 31267 (0.5 0.3)
+ 31254 (0.5 0.3)

$4,342.04

31267

$3,052.37

ESS (maxillary only)

CDT = Current Dental Terminology; CPT = current Procedural Terminology; ESS = endoscopic sinus surgery; MSG = maxillary sinus bone grafting;
RCTx = root canal therapy.

TABLE IV.
Overall Expected Costs of Primary Dental and Sinus Surgical Treatment Pathways for Odontogenic Sinusitis Due to Apical Periodontitis.
Primary Treatment Pathways

In-Network Dental Costs
Cost With All Diseased
Sinuses Opened
During ESS

Out-of-Network Dental Costs

Cost With Maxillary
Antrostomy Alone
During ESS

Cost With All Diseased
Sinuses Opened
During ESS

Cost With Maxillary
Antrostomy Alone
During ESS

Primary extraction

$4,753.83

$4,237.96

$6,018.97

$5,503.10

Primary RCTx

$4,677.34

$4,160.53

$5,553.95

$5,037.96

Primary ESS

$7,319.85

$6,030.18

$8,391.59

$7,101.92

ESS = endoscopic sinus surgery; RCTx = root canal therapy.

consultation. No posttreatment clinic costs were modeled as
these are included in dental treatment costs. For ESS, models
included one preoperative consultation plus nasal endoscopy,
and two postoperative visits (ﬁrst with endoscopic debridement,
second with routine endoscopy).
Cost of the following variables were excluded: dental and
sinus imaging, oral antibiotics, oral or topical corticosteroids,
over-the-counter medications, CT image navigation (CPT 61782),
anesthesia, and treatment-related complications.
Supporting Table SI shows individual CDT codes and
descriptions that comprised different dental treatment options,
with their average in-network and out-of-network costs and 95%
CIs. Supporting Table SII shows CPT codes, costs, and 95% CIs
for ESS options used in models.
Table III shows CDT and CPT code combinations used to
model each treatment and their costs. For dental treatments,
costs are highlighted as in-network or out-of-network. For ESS,
costs are reported as maxillary only or all diseased sinuses being
opened.

Analytic Approach
Cost and sensitivity analyses were performed using
TreeAge Pro Healthcare Module 2021 (TreeAge Software, Inc.,
Williamstown, MA, USA). For initial cost estimates of the three
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treatment models, average costs for ESS addressing all diseased
sinuses and in-network dental care were used.
Sensitivity analysis was conducted in two ways. First, three
alternative scenarios were modeled that involved changing one
or more cost parameters: ESS with maxillary antrostomy alone,
out-of-network dental costs, or both. The second sensitivity analysis examined the effects of 20% increases or decreases in all cost
values, and 10% increases or decreases in all probabilities. This
was done for the primary ESS pathway since it was likely the
most expensive, and whether alternative inputs could change
that conclusion was of interest. This was also done for the primary extraction pathway since the initial treatment cost was
small relative to subsequent treatment costs (as opposed to the
RCTx or ESS decision trees). Therefore, the relative importance
of variation in initial treatment costs versus subsequent treatment costs could be examined. For RCTx analysis, only the
effects of 20% variation in RCTx cost was assessed as this represented the strongest possible effect on the model.

RESULTS
Table IV shows expected costs of the three primary
treatment pathways for ODS due to AP in four different
scenarios: in-network and out-of-network dental costs,
Craig et al.: Costs of ODS Management

and ESS with all diseased sinuses or only maxillary sinus
being opened. The ﬁrst scenario modeling ESS for all
sinuses and in-network dental costs represented the
“base” scenario; the other 3 represented the ﬁrst form of
sensitivity analyses. Although changing input costs had
some inﬂuence on relative costs, expected costs of primary RCTx and extraction pathways were always lower
than primary ESS, regardless of dental care being innetwork or out-of-network, or ESS extent.
Expected costs of primary RCTx and extraction were
similar, ranging from $4,161 to $4,754 for in-network care
and $5,038 to $6,019 for out-of-network care. For in-network
care, primary extraction cost only about $80 more than primary RCTx. For out-of-network care, primary extraction
cost about $500 more than primary RCTx.
Expected primary ESS costs ranged from $6,030 to
$7,320 if subsequent dental care was for in-network work
and $7,102 to $8,392 for out-of-network dental care. For
primary ESS, addressing all diseased sinuses cost
approximately $1,300 more than maxillary antrostomy
alone, regardless of dental care being in-network or outof-network.
In the second set of sensitivity analyses, as expected,
variation in higher-cost and higher-probability treatments had more inﬂuence on expected costs than lessexpensive or lower-probability treatments. The expected
cost of primary ESS ranged from $6,449 to $8,186, with a
variation in ESS cost having the dominant effect on
expected cost. Expected cost of primary extraction ranged
from $4,365 to $5,101, with no single cost or probability
being most impactful. Expected primary RCTx cost
ranged from $4,197.34 to $5,157.34 when a 20% variation
in initial RCTx cost was assessed. Primary ESS was
therefore always the most expensive option.

DISCUSSION
ODS management success approaches 100% when
diseased dentition and affected sinuses are appropriately
treated.1 Treatment costs are increasingly important in
healthcare decision-making, but ODS treatment costs
have not been discussed in the literature. The current
study modeled different ODS treatment pathways and
their expected costs.
Based on this study’s models, primary ESS resulted
in higher expected costs than primary dental treatment
pathways. Two important assumptions drove the higher
cost of primary ESS. First, all patients undergoing primary ESS were assumed to require subsequent dental
treatments, whereas only about 50% of patients undergoing primary dental treatments would require subsequent
ESS. Second, ESS was only modeled in surgical centers.
Facility fees account for approximately 85% of total ESS
costs, which increases ESS costs compared to dental
treatments typically performed in the ofﬁce setting.
Although primary ESS has a higher expected cost, it
remains an important primary treatment option for some
ODS patients. Important considerations when selecting
between dental treatment and ESS options for ODS
include symptom burdens and insurance coverage. Primary ESS is particularly useful when sinonasal
Laryngoscope 00: 2021

symptoms are most prominent. Craig et al. demonstrated
resolution of sinus-related symptoms in 7 to 12 days after
primary ESS, compared to 35 to 56 days after primary
dental treatment.13 Primary dental treatment may be
better for those with tolerable sinonasal symptoms or
prominent dental symptoms. However, dental treatment
alone resolves ODS in only 50% to 60% of cases. Should
primary dental treatment fail, symptomatic patients may
suffer unnecessarily until undergoing ESS.
Another important consideration is the effect of
insurance coverage on costs incurred by ODS patients.
The American Dental Association reported that about
30% of adults had no dental insurance coverage, 60% had
private insurance, and 7% had Medicaid with dental beneﬁts.27 Comparatively, 92% of the US population had
health insurance (68% private, 34% public).28 Insurance
beneﬁts may have a signiﬁcant impact on patients’
expected out-of-pocket costs.
State-provided dental insurances vary substantially
with regard to coverage for nonpreventative care,
whereas private dental insurances generally cover 50% to
80% of costs up to the maximal annual coverage. For dental implants, state-provided insurance plans provide no
coverage, whereas private insurance generally covers
50% to 80% up to maximal annual coverage. Maximum
annual dental coverage may be as low as $1,000, varying
by state and insurance plan.29–32 ODS patients will likely
exceed their annual coverage if they undergo anything
other than dental extraction alone, especially if revision
dental treatments are required. Patients’ ﬁnancial
responsibilities for ESS vary substantially between different private,33 Medicare,34 and Medicaid35 insurance
plans. These factors could drive decision-making. For
example, patients without dental insurance or minimal
dental coverage may select primary ESS. Alternatively,
patients who have medical insurance plans with high outof-pocket costs may select primary dental treatments.
When pursuing dental treatment, ODS patients must
decide on preserving or extracting their diseased dentition,
but there are multiple factors to consider. One issue is that
for ODS, efﬁcacy data for dental treatment is limited. Dental extraction is the only primary dental treatment with
published success rates.9,10,36–38 While RCTx, revision
RCTx, and apicoectomy are options for managing ODS, they
have only been reported as standalone treatments in case
reports39,40 or small series.13,39–41 Interestingly, costs of primary RCTx and dental extraction were comparable, so
future studies assessing RCTx efﬁcacy in managing ODS
would be extremely valuable.
The purpose of RCTx in treating ODS due to AP is to
disinfect and obliterate the tooth’s infected pulp chambers,
which may or may not resolve PALs and sinusitis. Importantly, RCTx for maxillary molars is more challenging
than for non-molar teeth because maxillary molar roots
have more complex conﬁgurations or extra roots that can
be missed.42–44 Additionally, PALs increase the risk of
RCTx failure.45–47 Due to these complexities, the American
Association of Endodontists suggested endodontists perform endodontic therapies of maxillary molars.48
Considering the technical complexities and lack of
published success of endodontic therapies for ODS, dental
Craig et al.: Costs of ODS Management

7

extraction may seem simpler and more effective, but
there are important issues to consider. First, maxillary
molar extractions can be challenging due to their root
anatomy. Even with optimal techniques, these extractions can lead to oroantral communication, retained or
displaced root fragments, and alveolar fractures.49 Second, patients must decide if and how their lost dentition
is replaced. Although least expensive to have no reconstruction, there are functional and cosmetic concerns with
this option. Tooth loss will result in decreased masticatory efﬁciency, and cosmetic deﬁcits depending on tooth
location and smile line. Additionally after dental extraction, patients lose substantial alveolar bone volume over
time,50–53 which complicates future implant placement.
If patients choose to undergo dental reconstruction,
they must decide between partial dentures, bridges, and
dental implants. Dental implants have become popular
because in contrast to other options, they preserve adjacent tooth structure and bone, and enhance masticatory
function and quality of life.54 However, dental implants
are expensive, especially when MSG is necessary. For
implant success, ≥4 to 6 mm of maxillary alveolar bone
height is necessary, below which MSG is recommended.55–57 MSG is often necessary after maxillary
molar extractions, and may be more likely in ODS due to
frequent periapical bone erosion. The cost of implant plus
MSG is two to three times more than other reconstructive
options, and this cost must be weighed against implant
functionality. Partial dentures are the least expensive
reconstructive option, but they provide minimal masticatory support. Bridges fall between partial denture and
implant costs, but they result in damage to healthy abutment teeth, placing them at risk for caries and endodontic
disease.58
For patients undergoing ESS, the extent of surgery
is another important consideration. Safadi et al. showed
that maxillary antrostomy alone was sufﬁcient for ODS
with frontal sinus involvement,21 shortening operative
time and decreasing surgical risks. Based on the current
study, expected cost of maxillary antrostomy alone was
about $1,300 less than opening all diseased sinuses. More
studies are necessary to assess whether the potential
decreases in risks and costs with maxillary antrostomy
alone compare favorably with clinical outcomes from
opening all diseased sinuses.

Limitations
Costs of certain components of ODS management
were not modeled. This was generally due to those components having inadequate published data, being impractical to model, or being nominal compared to other costs.
For example, some out-of-pocket nominal costs were not
modeled such as nasal saline sprays or irrigations, or
over-the-counter analgesics like acetaminophen or nonsteroidal anti-inﬂammatory medications. Additionally,
costs for imaging, CT image navigation, antibiotic use,
and anesthesia were not modeled in this study.
Imaging studies needed may include periapical
X-rays, orthopantograms, cone-beam CT, and sinus CT
scans.59 Costs of these imaging modalities range from $25
Laryngoscope 00: 2021
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to $225.23,24 CT image navigation was also not modeled,
as image navigation use is variable across surgeons, and
the cost would be approximately $175 to $195.24 Although
these variables do not represent a signiﬁcant proportion
of ODS management costs, patients should expect to
incur these costs.
Antibiotic costs were not modeled because little evidence exists with regard to the utility of antibiotics for
ODS.14 Additionally, antibiotic use would be equivalent
between all three treatment pathways.
Anesthesia costs were also not incorporated into
models for two reasons. First, there is signiﬁcant variability in dental practice patterns with respect to anesthesia
types used. Secondly, the anticipated general
anesthesia cost for ESS is $200 to $400,60 and this cost
was felt to be nominal for modeling. However, anesthesia
costs would generally be lower for dental treatments as
most extractions and endodontic therapies are done
under local anesthesia.
Next, the assumption that all treatments were ultimately 100% effective does not capture the duration of
time elapsed over the course of dental and otolaryngologic
evaluations and treatments. Ly and Hellgren showed that
ODS patients experienced an average 18 week delay from
Otolaryngology referral to dental consultation, and an
additional 22 week delay from time of dental diagnosis to
treatment.61 Delays in evaluation, treatment, and disease
resolution could impact the effectiveness of different ODS
treatment pathways and should be considered in future
studies.
Another point to consider is that this study modeled
direct healthcare costs, but did not measure indirect costs
related to productivity loss or missed workdays. Since
ESS can lead to more rapid symptom resolution in ODS,
it is possible that it could lead to less productivity loss or
missed workdays compared to primary dental treatments,
and these indirect costs should be considered in future
studies.
Another model limitation was that it was presumed
that dental extraction would resolve AP in 100% of cases,
and ESS would resolve the sinusitis in ODS patients in
100% of cases. Similarly, MSG and dental implants were
presumed to be performed with 100% success. Each of
these interventions can potentially fail, with substantial
costs related to retreatments. Patients should be educated on the potential for such treatment failures.
Lastly, this study only modeled costs of managing
uncomplicated ODS on an elective basis. While rare, ODS
can lead to extrasinus infectious complications requiring
hospitalization.62 Expected costs of complicated ODS care
would be substantially greater than uncomplicated ODS,
and future studies could explore such costs.

CONCLUSION
ODS due to AP can be successfully treated with primary dental treatments, but ESS is still frequently
required. This study showed that expected costs of primary dental extraction and RCTx were roughly equal.
Primary ESS had a higher expected cost, but may still be
preferred in patients with severe sinonasal symptoms.
Craig et al.: Costs of ODS Management

Patients’ insurance coverage may also impact decisionmaking.
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